US Pharmatech Inc.

New Filing

CIK: 0002105777·Manufacturing·CALIFORNIA·Filed: Jan 16, 2026

Total Offering

$3,403,700

Amount Sold

$3,403,700

Investors

1

First Sale

Dec 31, 2025

Offering Details

Type: Debt
Exemptions: Rule 506(b)
Entity Type: Corporation
Non-Accredited Investors: Yes

Related Persons

Name	Role
Dong Jun Lee	Executive Officer

Company

US Pharmatech Inc.

14108 ARTESIA BLVD.

CERRITOS, CA, 90703

6505159348

SEC Filing

0002105777-26-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.